Retinitis Pigmentosa is a genetic form of vision loss. While rare, its impact on day-to-day living can be devastating, especially as symptoms usually start in early childhood. Now, an important advance in gene-based treatment is offering new hope to many patients.
About the author
Monica Matys
Monica Matys is a Communications Advisor at Sunnybrook.
Have a question about this post? Get in touch.
Read more
One patient’s story of life after cancer treatment
The wait is over – the solar eclipse is happening today! Are you prepared to watch it safely?
Clinical trials provide hope for people living with early-stage Alzheimer’s: Janice’s story
A Creative Soul Proves the Value of Art Therapy
A Journey of Hope: How Breast Cancer Patient Ada Nolan Overcame the Odds
